Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in goats

Veterinary Journal

Volumn 184, Issue 2, 2010, Pages 219-229

  Sidhu, P K ^a   Landoni, M F ^b   AliAbadi, F S ^c   Lees, P ^d  

^a GURU ANGAD DEV VETERINARY AND ANIMAL SCIENCES UNIVERSITY   (India)

^b FACULTAD DE CIENCIAS VETERINARIAS   (Argentina)

^c Food Quality Control Laboratory   (Iran)

^d ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Dose determination; Marbofloxacin; Pharmacodynamics; Pharmacokinetics; PK PD integration; PK PD modelling; Tolfenamic acid

Indexed keywords

MARBOFLOXACIN; TOLFENAMIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BACTERICIDAL ACTIVITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EX VIVO STUDY; FEMALE; GOAT; MANNHEIMIA HAEMOLYTICA; MATHEMATICAL MODEL; MEAN RESIDENCE TIME; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; PHARMACODYNAMICS; PLASMA CONCENTRATION-TIME CURVE; PNEUMONIC PASTEURELLOSIS;

ANIMALS; ANTHRANILIC ACIDS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; FLUOROQUINOLONES; GOAT DISEASES; GOATS; INJECTIONS, INTRAMUSCULAR; MANNHEIMIA HAEMOLYTICA; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; PASTEURELLACEAE INFECTIONS;

BACTERIA (MICROORGANISMS); CAPRA; CAPRA HIRCUS; MANNHEIMIA HAEMOLYTICA;

EID: 77649183124     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2009.02.009     Document Type: Article

References (58)

1. Albarellos G.A., Montoya L., and Landoni M.F. Pharmacokinetics of marbofloxacin after single intravenous and repeat oral administration to cats. The Veterinary Journal 170 (2005) 222-229
2. Aliabadi F.S., and Lees P. Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research 62 (2001) 1979-1989
3. Aliabadi F.S., and Lees P. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate. Journal of Veterinary Pharmacology and Therapeutics 25 (2002) 161-174
4. Aliabadi F.S., Landoni M.F., and Lees P. Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrobial Agents and Chemotherapy 47 (2003) 626-635
5. Bidgood T.L., and Papich M.G. Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs. Journal of Veterinary Pharmacology and Therapeutics 28 (2005) 329-341
6. Brown S.A. Fluoroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics 19 (1996) 1-14
7. Clarke C.R. Tissue-chamber modelling systems - applications in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 12 (1989) 349-368
8. Clarke C.R., Short C.R., Bourne D.W.A., and Usenik E.A. Subcutaneously implanted tissue chambers - a pharmacokinetic study. Journal of Veterinary Pharmacology and Therapeutics 12 (1989) 312-321
9. Cotard J.P., Gruet P., Pechereau D., Moreau P., Pages J.P., Thomas E., and Deleforge J. Comparative study of marbofloxacin and amoxicillin-clavulanic acid in the treatment of urinary tract infections in dogs. Journal of Small Animal Practice 36 (1995) 349-353
10. Deleforge J., Thomas E., Davot J.L., and Boisrame B. A field evaluation of the efficacy of tolfenamic acid and oxytetracycline in the treatment of bovine respiratory disease. Journal of Veterinary Pharmacology and Therapeutics 17 (1994) 43-47
11. Dova S.W., San Andres M.D., Gonzalez F., San Andres M.I., De Lucas J.J., and Rodriquez C. Pharmacokinetic behaviour and pharmacokinetic-pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats. The Veterinary Journal 174 (2007) 425-427
12. Drusano G.L. Prevention of resistance: a goal for dose selection for antimicrobial agents. Clinical Infectious Diseases 36 Suppl. (2003) S42-S50
13. Dutta N.K., Mazumdar K., Dastidar S.G., and Park J.H. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice. International Journal of Antimicrobial Agents 30 (2007) 336-340
14. Fabrega A., Sanches-Cespedes J., Soto S., and Vila J. Quinolone resistance in the food chain. International Journal of Antimicrobial Agents 31 (2008) 307-315
15. Forrest A., Nix D.E., and Ballow C.H. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy 37 (1993) 1073-1081
16. Frazier D.L., Thompson L., Trettien A., and Evans E.I. Comparison of fluoroquinolone pharmacokinetic parameters after treatment with marbofloxacin, enrofloxacin and difloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics 23 (2000) 293-302
17. Heinen E. Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration. Journal of Veterinary Pharmacology and Therapeutics 25 (2002) 1-5
18. Higgins A.J., Lees P., and Wright J.A. Tissue-cage model for the collection of inflammatory exudate in ponies. Research in Veterinary Science 36 (1984) 284-289
19. Higgins A.J., Lees P., and Sedgewick A.D. Development of equine models of inflammation. Veterinary Record 120 (1987) 517-522
20. Ismail M., and El-Kattan Y.A. Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves. Research in Veterinary Science 82 (2007) 398-404
21. Kissane, J.M., 1997. Bacterial Diseases. In: Anderson, W.A.D., Kissane, JM. (Eds.), Pathology. Mosby, St. Louis, MO. pp. 369-414.
22. Kruszewska H., Zareba T., and Tyski S. Search of antimicrobial activity of selected non-antibiotic drugs. Acta Polica Pharmacologia 59 (2002) 436-439
23. Laraje R., Talmi A., Bounaga R., Bengoumi M., El Hraiki A., and Laurentie M. Comparative pharmacokinetics of marbofloxacin after a single intramuscular administration at two dosages to camels (Camelus dromedarius). Journal of Veterinary Pharmacology and Therapeutics 29 (2006) 229-231
24. Lees P., Higgins A.J., Sedgewick A.D., and May S.A. Applications of equine models of acute inflammation. Veterinary Record 120 (1987) 522-529
25. Lees P., Aliabadi F.S., and Toutain P.L. PK-PD modeling: an alternative to dose titration studies for antimicrobial drug dosage selection. Journal of Regulatory Affairs 15 (2004) 175-180
26. Lees P., Concordet D., Aliabadi F.S., and Toutain P.L. Drug selection and optimization of dosage schedules to minimize antimicrobial resistance. In: Aarestrup F.M. (Ed). Antimicrobial Resistance in Bacteria of Animal Origin (2006), ASM Press, Washington, DC 49-71
27. McKellar Q.A., Gibson F.I., and McCormack Z.R. Pharmacokinetics and tissue disposition of danofloxacin in sheep. Biopharmaceutics and Drug Disposition 19 (1998) 123-129
28. McKellar Q.A., Gibson F.I., Monteiro A., and Bregante M. Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration. Antimicrobial Agents and Chemotherapy 43 (1999) 1988-1992
29. Olofsson S.K., Marcusson L.L., Lindgren P.K., Hughes D., and Cars O. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: resistance between drug exposure and mutant prevention concentration. Journal of Antimicrobial Chemotherapy 57 (2006) 1116-1121
30. Perrier D., and Mayersohn M. Noncompartmental determination of the steady-state volume of distribution for any mode of administration. Journal of Pharmaceutical Sciences 71 (1982) 372-373
31. Petracca K., Riond J.L., Graser T., and Wanner M. Pharmacokinetics of the gyrase inhibitor marbofloxacin: influence of pregnancy and lactation in sows. Journal of Veterinary Medical Association 40 (1993) 73-79
32. Peyrou M., Bousquet-Melou A., Laroute V., Vrins A., and Doucet M.Y. Enrofloxacin and marbofloxacin in horses: comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate first-pass effect and absorbed fraction. Journal of Veterinary Pharmacology and Therapeutics 29 (2006) 337-344
33. Robertson S.A., and Taylor P.M. Pain management in cats - past, present and future. Part-2. Treatment of pain-clinical pharmacology. Journal of Feline Medical Surgery 6 (2004) 321-333
34. Sarasola P., Lees P., Aliabadi F.S., McKellar Q.A., Donachie W., Marr K.A., Sunderland S.J., and Rowan T.G. Pharmacokinetic and pharmacodynamic profiles of danofloxacin administered by two dosing regimens in calves infected with Mannheimia (Pasteurella) haemolytica. Antimicrobial Agents and Chemotherapy 46 (2002) 3013-3019
35. Schneider M., Thomas V., Boisrame B., and Deleforge J. Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration. Journal of Veterinary Pharmacology and Therapeutics 19 (1996) 56-61
36. Shem-Tov M., Ziv G., Glickman A., and Saran A. Pharmacokinetics and penetration of marbofloxacin from blood into the milk of cows and ewes. Journal of the American Veterinary Medical Association 44 (1997) 511-519
37. Sidhu, P.K. 2001. Pharmacokinetics and pharmacodynamics of marbofloxacin and tolfenamic acid in ruminant species. PhD Thesis, University of London, London, United Kingdom.
38. Sidhu P.K., Aliabadi F.S., Andrews M., and Lees P. Tissue chamber model of acute inflammation in farm animal species. Research in Veterinary Science 74 (2003) 67-77
39. Sidhu P.K., Landoni M.F., and Lees P. Influence of marbofloxacin on the pharmacokinetics and pharmacodynamics of tolfenamic acid in calves. Journal of Veterinary Pharmacology and Therapeutics 28 (2005) 109-119
40. Sidhu P.K., Alibadi F.S., Landoni M.F., and Lees P. Pharmacokinetic and pharmacodynamic interactions of marbofloxacin with tolfenamic acid in calves. Journal of Veterinary Pharmacology and Therapeutics 29 Suppl. 1 (2006) 253-254
41. Sidhu P.K., Landoni M.F., and Lees P. Pharmacokinetic and pharmacodynamic interactions of tolfenamic acid and marbofloxacin in goats. Research in Veterinary Science 80 (2006) 79-90
42. Spreng M., Deleforge J., Thomas V., Boisrame B., and Drugeon H. Antibacterial activity of marbofloxacin: a new fluoroquinolone for veterinary use against canine and feline isolates. Journal of Veterinary Pharmacology and Therapeutics 18 (1995) 284-289
43. Sullivan M., Cooper B.W., Nightingale C.H., Quintiliani R., and Lawlor M.T. Evaluation of the efficacy of the ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model. Antimicrobial Agents and Chemotherapy 37 (1993) 234-239
44. Thomas V., Deleforge J., and Boisrame B. Pharmacokinectics of marbofloxacin in pre-ruminant and ruminant cattle. Sixth EAVPT Congress Proceedings (1994), Blackwell Scientific Publications, Edinburgh, Scotland 60-61
45. Thomas V., Deleforge J., Boisrame B., and Espinasse J. Pharmacokinectics of marbofloxacin in healthy and sick pre-ruminant calves. Sixth EAVPT Congress Proceedings (1994), Blackwell Scientific Publications, Edinburgh, Scotland 61
46. Thomas V.M., Guillardeau L.D., Thomas E.R., and Boisrame B. Update on the sensitivity of recent European canine and feline pathogens to marbofloxacin. Veterinary Quarterly 19 Suppl. 1 (1997) 52-53
47. Thomas V., Gruet P., Pommier P., and Wessel-Robert S. Maladies respiratoives des porcs charcutiers: Marbocyl 2% versus amoxycilline. Action Veterinaire 1462 (1998) 14-15
48. Thomas E., Madelenat A., Davot J.L., and Boisrame B. Clinical efficacy and tolerance of marbofloxacin and tetracycline in the treatment of bovine respiratory disease. Revue Medecine Vétérinaire 174 (1998) 21-27
49. Thomas E., Caldow G.L., Borell D., and Davot J.L. A field comparison of the efficacy and tolerance of marbofloxacin in the treatment of bovine respiratory disease. Journal of Veterinary Pharmacology and Therapeutics 24 (2001) 353-358
50. Thomas A., Nicolas C., Dizier I., Mainil J., and Linden A. Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium. Veterinary Record 153 (2003) 428-431
51. Toutain P.L. Pharmacokinetics/pharmacodynamics integration in drug development and dosage regimen optimization for veterinary medicine. AAPS Pharmaceutical Sciences 4 (2002) E38
52. Toutain P.L. Pharmacokinetics/pharmacodynamics integration in dosage regimen optimization for veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 26 Suppl. 1 (2003) 1-8
53. Toutain P.L. Antibiotic treatment of animals - a different approach to rational dosing. The Veterinary Journal 165 (2003) 98-100
54. Toutain P.L., and Lees P. Integration and modeling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 467-477
55. Waxman S., Rodriguez C., Gonzalez F., De Vicente M.L., San Andres M.I., and San Andres M.D. Pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in adult goats. Journal of Veterinary Pharmacology and Therapeutics 24 (2001) 375-378
56. Waxman S., San Andres M.D., Gonzalez F., De Lucas J.J., San Andres M.I., and Rodriguez C. Influence of Escherichia coli endotoxin-induced fever on the pharmacokinetic behaviour of marbofloxacin after intravenous administration in goats. Journal of Veterinary Pharmacology and Therapeutics 26 (2003) 65-69
57. Waxman S., San Andres M.D., Gonzalez F., San Andres M.I., De Lucas J.J., and Rodriguez C. Age-related changes in the pharmacokinetics of marbofloxacin after intravenous administration in goats. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 31-35
58. Wolfson J.S., and Hooper D.C. Pharmacokinetics of quinolones: newer aspects. European Journal of Clinical Microbiology and Infection 10 (1991) 267-274